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IL-18-induced expression of high-affinity IL-2R
on murine NK cells is essential for NK-cell IFN-γ
production during murine Plasmodium yoelii infection
Kerstin A. Stegmann1, J. Brian De Souza1,2 and Eleanor M. Riley1
1 Faculty of Infectious and Tropical Diseases, Department of Immunology and Infection,
London School of Hygiene and Tropical Medicine, London, UK
2 Division of Infection and Immunity, University College London, London, UK
Early production of pro-inflammatory cytokines, including IFN-γ, is essential for con-
trol of blood-stage malaria infections. We have shown that IFN-γ production can be
induced among human natural killer (NK) cells by coculture with Plasmodium falciparum
infected erythrocytes, but the importance of this response is unclear. To further explore
the role of NK cells during malaria infection, we have characterized the NK-cell response
of C57BL/6 mice during lethal (PyYM) or nonlethal (Py17XNL) P. yoelii infection. Ex vivo
flow cytometry revealed that NK cells are activated within 24 h of Py17XNL blood-stage
infection, expressing CD25 and producing IFN-γ; this response was blunted and delayed
during PyYM infection. CD25 expression and IFN-γ production were highly correlated,
suggesting a causal relationship between the two responses. Subsequent in vitro exper-
iments revealed that IL-18 signaling is essential for induction of CD25 and synergizes
with IL-12 to enhance CD25 expression on splenic NK cells. In accordance with this,
Py17XNL-infected erythrocytes induced NK-cell CD25 expression and IFN-γ production in
a manner that is completely IL-18- and partially IL-12-dependent, and IFN-γ production
is enhanced by IL-2. These data suggest that IL-2 signaling via CD25 amplifies IL-18- and
IL-12-mediated NK-cell activation during malaria infection.
Keywords: CD25  IL-12  IL-18  Malaria  NK cells
 Additional supporting information may be found in the online version of this article at thepublisher’s web-site
Introduction
Malaria is a major global health problem causing in excess of
600,000 deaths per year, 80% of these in sub-Saharan Africa [1].
Human immunoepidemiological studies as well as murine models
of Plasmodium spp. infection have proven valuable in elucidating
both innate and adaptive responses to malaria and their contri-
bution to protective immunity [2, 3]. Collectively, these studies
suggest an important role for the cytokine IFN-γ in clearance of
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blood-stage infections. In particular, a robust IFN-γ response in the
first 24–48 h after blood-stage infection correlates with a favorable
outcome and long-term survival in mouse models [4, 5]. Although
a number of immune cells have been reported to produce IFN-γ, T
lymphocytes and natural killer (NK) cells are by far the most pro-
ficient producers of this cytokine [6] suggesting that they may be
key players in protective immunity to malaria.
Freshly isolated human NK cells can produce large amounts
of IFN-γ within 12–18 h of coculture with Plasmodium falciparum
infected red blood cells (iRBCs) [7, 8]. NK-cell activation depends
upon cytokine (IL-12 and IL-18) and contact-dependent signals
from monocytes and myeloid DCs [9] and is markedly ampli-
fied by IL-2 [10]. Importantly, recent evidence from a humanized
C© 2015 The Authors. European Journal of Immunology published by WILEY-VCH Verlag GmbH & Co.
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mouse model indicates that human NK cells can eliminate P. falci-
parum iRBC [11]. The role of NK cells during murine blood-stage
malaria infections is however disputed and their mode of activa-
tion is less well studied, although there is a clear role for IL-12 [2].
Proliferation and expansion of the peripheral blood NK-cell pop-
ulation, together with upregulation of interferon associated gene
transcripts, occurs within the first 24 h of Plasmodium chabaudi
infection [12] and NK depletion with anti-asialo GM1 antibodies
leads to higher parasitemia, reduced DC activation, and reduced
CD4+ T-cell priming [13, 14]. However, NK-cell depletion with
anti-NK1.1 antibodies reportedly either increased mortality [15]
or had no effect on the course of P. chabaudi infection [16]. In Plas-
modium berghei XAT infections, NK-cell lytic activity is increased
but NK depletion with anti-NK1.1 antibodies does not affect par-
asite clearance [17]. In nonlethal Plasmodium yoelii infections,
NK cells have been shown to contribute to liver-stage immunity
[18, 19] and to be activated and secrete IFN-γ during the first
24 h of blood-stage infection [5, 20] but their contribution to
protection is disputed; much less in the way of NK activation is
observed during the early stage of lethal P. yoelii infections [20].
Some of this confusion may arise from the lack, until recently, of
highly specific reagents for identification and depletion of murine
NK cells: both anti-CD49b (DX5) and anti-NK1.1 mark and delete
subsets of T cells as well as NK cells. However, the identification of
NKp46 as a highly specific NK-cell marker [21] is allowing a more
precise analysis of their role during malaria and other infections.
Here, we have investigated the very early NK-cell response to
two closely related strains of the rodent malaria parasite, P. yoelii
(Py) Py17XNL causes a self-resolving infection whereas PyYM
replicates very rapidly, killing infected mice within 1 week. We
find that NK cells are more quickly and more extensively acti-
vated during nonlethal Py17XNL infection than during lethal PyYM
infection, that this correlates with more rapid and more extensive
upregulation of the IL-2 receptor α-subunit (CD25) and thus with
expression of high-affinity IL-2 receptor, and that expression of
CD25 and secretion of IFN-γ by NK cells is partially dependent
upon IL-12, is augmented by IL-2, and totally dependent upon
signaling through the IL-18 receptor.
Results
NK cells upregulate the high-affinity IL-2R and secrete
IFN-γ within 24 h of P. yoelii infection
In line with previous studies [20], iRBC became visible by
microscopy approximately 5 days postinfection (p.i.) with 105
nonlethal Py17XNL iRBC (Fig. 1A); parasitemia increased to a
peak of approximately 30% from 17 to 21 days p.i. and was
cleared by 28 days p.i. By contrast, during lethal PyYM infection,
iRBC became visible by day 3 p.i. and parasitemia reached approx-
imately 35% by 6 days p.i. (Fig. 1B) when mice were euthanized
(according to welfare guidelines).
Splenic NK-cell responses were analyzed directly ex vivo by
flow cytometry. After exclusion of cell aggregates and dead cells,
NK cells were identified as CD3− and NKp46+ lymphocytes and
examined for expression of functional markers (Fig. 1C). In line
with previous studies [4, 5, 22], IFN-γ was induced in NK cells
within 24 h of nonlethal Py17XNL infection; CD69 and, somewhat
surprisingly, CD25 were also induced on NK cells. TNF, TRAIL,
and CD107a were modestly upregulated but there was little or no
change in Granzyme B or CD122 expression (Fig. 1D). NK cells
were also activated—although to a lesser extent—during the first
24 h of lethal PyYM infection (Fig. 1D) with IFN-γ production,
CD69 and CD25 expression being upregulated in some but not all
animals.
To determine whether differences in the extent of NK-cell
activation simply reflected a difference in the timing of the NK
response between the two infections, we compared NK-cell expres-
sion of IFN-γ, CD25, and CD122 in Py17XNL and PyYM infected
mice over the first week of infection (Figs. 2 and 3). In mice with
nonlethal Py17XNL infections, NK-cell IFN-γ production was max-
imal on day 1 p.i. (Figs. 2A and3A) and this coincided with the
peak of CD25 expression (Figs. 2A and3B). Indeed, the proportion
of NK cells expressing CD25was very tightly correlated (r2 = 0.81)
with the proportion of NK cells producing IFN-γ (Fig. 3E). By con-
trast, among mice with lethal PyYM infections, the NK-cell IFN-γ
response was less robust on day 1 p.i. andwas sustained until day 6
p.i. (when themice were culled due to high parasitemia) (Fig. 3C).
Strikingly, CD25 was upregulated much more gradually in PyYM-
infected mice, being maximal at day 6 p.i. (Fig. 3D). Nevertheless,
there was a significant correlation between IFN-γ production and
CD25 expression in lethal PyYM infections (Fig. 3E).
To directly test the link between CD25 expression and IFN-γ
production, splenocytes from P. yoelii infected animals (24 h p.i.)
and control (uninfected) animals were cultured in vitro with or
without 100 ng/mL IL-2 for 4 h and analyzed for IFN-γ expression
by flow cytometry (Fig. 3F). Splenic NK cells from uninfected
animals expressed low levels of CD25 (Fig. 3B and D) and very
few cells produced IFN-γ irrespective of the presence or absence of
IL-2. By contrast, IFN-γ production byNK cells from both Py17XNL-
infected and PyYM-infected mice was markedly upregulated in the
presence of IL-2 with a trend, although not statistically significant,
toward a higher IFN-γ production by NK cells from Py17XNL-
infected mice than in NK cells from PyYM-infected mice (Fig. 3F).
These data confirm recent reports of CD25 upregulation on
murine NK cells during acute murine cytomegalovirus (MCMV)
infection [23], indicate that CD25 expression might be causally
associated with IFN-γ production, and suggest (but do not prove)
that a very rapid (24 h) and robust NK-cell CD25/IFN-γ response
may be associated with successful resolution of P. yoelii infection.
IL-12 and IL-18 synergize to induce CD25 expression
on murine NK cells
Since IL-12 and IL-18 are associated with induction of IFN-γ in
both mouse [24–26] and human [27, 28] NK cells, we wondered
whether IL-12 and/or IL-18might mediate this effect via induction
of CD25. Splenic NK cells from uninfected mice were incubated
for 2, 4, or 6 h with increasing concentrations of IL-12, IL-18, or
IL-12 plus IL-18 and analyzed for IFN-γ and CD25 expression by
C© 2015 The Authors. European Journal of Immunology published by
WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
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Figure 1. Early NK-cell activation during lethal and nonlethal P. yoelii infection. C57BL/6 mice were infected i.p. with 105 RBCs infected with (A)
P. yoelii 17XNL or (B) P. yoelii YM. Each line represents the mean (SEM) parasitemia for groups of three to five mice in each of three (A) or two
(B) independent experiments. (C) Splenic NK cells were identified by flow cytometry. Lymphocytes were gated after exclusion of cell aggregates,
followed by exclusion of dead cells. NK cells were identified as NKp46+ CD3ε– lymphocytes. Overlays are shown for activation and functional
markers. Black = naive animal; red = day 1 of P. yoelii 17XNL infection. (D) Changes (fold increase) in frequency (%) or expression levels (MFI) of
activation and functional markers on murine splenic NK cells 24 h after infection with P. yoelii 17XNL or P. yoelii YM compared to naive controls
were determined by flow cytometry. Data are shown as mean, SEM, and range for P. yoelii 17XNL (n = 13 mice) and P. yoelii YM (n = 10 mice)
infection pooled from three (Py17XNL) or two (PyYM) independent experiments.
C© 2015 The Authors. European Journal of Immunology published by
WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
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Figure 2. Expression of CD25 and IFN-γ by splenic NK cells during nonlethal P. yoelii infection. Representative flow cytometry histograms of CD122
and CD25 expression and dot plots of IFN-γ expression by NK cells (NKp46+CD3ε−) on days 0, 1, 3, and 6 or 7 after infection with (A) P. yoelii 17XNL
or (B) P. yoelii YM. The gating strategy was as shown in Figure 1C. The percentages of positive cells and the MFI of the entire NKp46+ population
are shown.
flow cytometry (Fig. 4A). In an initial experiment, as little as 1.25
ng/mL IL-12 for 6 h was sufficient to induce CD25 expression
on more than 50% of NK cells and further increasing the IL-12
concentration did not significantly increase either the proportion
of CD25+ cells (Fig. 4A) or the MFI of CD25 expression (Fig. 4B).
Similarly, 1.25 ng/mL of IL-18 was sufficient to induce CD25 on
more than 30% of NK cells and 2.5 ng/mL IL-18 induced CD25
expression on more than 50% of NK cells (Fig. 4A). Interestingly,
IL-12 alone induced a proportion of the CD25+ NK cells within
the splenocyte population to express IFN-γ, whereas IL-18 alone
did not induce IFN-γ secretion (Fig. 4A). There was clear evidence
of synergy between these two cytokines with 1.25 ng/mL of each
inducing more than 80% of NK cells to express CD25 (Fig. 4A);
the vast majority of these cells also expressed IFN-γ.
To investigate further this synergy between IL-12 and IL-18,
we examined upregulation of CD25 in response to even lower
concentrations of IL-12, over shorter incubation times (Fig. 4C).
Although no CD25 upregulation was evident at 2 h, as little as 0.04
ng/mL IL-12 in combination with 1.25 ng/mL IL-18 was sufficient
to markedly upregulate CD25 within 4 h (Fig. 4C, lower plot). In
terms of IFN-γ production, low concentrations of IL-12 alone or
IL-18 alone had little effect on NK-cell IFN-γ production, but very
low concentrations of IL-12 and IL-18 together (1.25 ng/mL of
each) were able to induce more than 80% of NK cells to produce
IFN-γ (Fig. 4D).
IL-18 signaling is essential for CD25 expression and
IFN-γ production by NK cells during P. yoelii infection
As NK-cell CD25 expression and IFN-γ production are both
induced during P. yoelii infection, IFN-γ secretion is highly cor-
related with CD25 expression and enhanced by exogenous IL-
2, and CD25 is induced in vitro upon IL-12 and IL-18 stimu-
lation, we hypothesized that P. yoelii iRBC would induce IL-12
and/or IL-18 secretion from monocytes or DCs and that these
cytokines would then induce CD25 expression and IFN-γ produc-
tion from NK cells. To test this hypothesis, we cultured splenocytes
from na¨ıve (uninfected) C57BL/B6 mice, IL-12 deficient mice (IL-
12p35−/−), or mice lacking the IL-18 receptor (IL-18R−/−) with
Py17XNL iRBC or, as a control, uninfected RBCs (uRBC). In wild-
type (WT) C57BL/6 mice, uRBC induced modest upregulation of
CD25, whereas iRBC induced a very marked (Fig. 5A) and highly
significant (Fig. 5B) upregulation of CD25 on NK cells. CD25
upregulation by iRBC was modestly reduced in mice lacking IL-
12p35 indicating that NK-cell activation is partly IL-12 dependent.
By contrast, iRBC-induced upregulation of CD25 was completely
ablated in IL-18R−/– mice, revealing an essential role for IL-18 in
upregulation of the high-affinity IL-2 receptor in response to P.
yoelii. As confirmation of this, neutralizing antibodies to IL-12 and
IL-18 completely ablated CD25 expression in WT and IL-12p35
deficient mice (Fig. 5A and B).
C© 2015 The Authors. European Journal of Immunology published by
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Figure 3. Association between NK-cell expression of CD25 and IFN-γ during lethal and nonlethal P. yoelii infection. (A–D) Mice were infected with
(A, B) P. yoelii 17XNL or (C, D) P. yoelii YM and splenic NK cells were analyzed ex vivo in the first 6–10 days of infection for expression of IFN-γ (A,
C) and CD25 (B, D) by flow cytometry. The gating strategy was as shown in Figure 1C. (E) Correlation between ex vivo IFN-γ and CD25 expression
among NK cells collected on day 1 p.i. (Py17XNL filled diamonds; PyYM gray diamonds). (F) Percentage of splenic NK cells from uninfected (d0)
or 1 day p.i. (d1) mice expressing IFN-γ after coculture for 4 h with or without 100 ng/mL exogenous rIL-2 (with Brefeldin A present for the last
3 h). Data points for individual mice, pooled from two (PyYM) or three (Py17XNL) independent experiments are shown (n = 10 for PyYM and n =
13 for Py17XNL). The Kruskal–Wallis plus Dunn’s post-test was used to compare experimental animals versus control (d0) animals (A–D) and the
Wilcoxon test was used to compare IL-2-stimulated and unstimulated samples (F). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
To further investigate the functional relationship between
expression of the high-affinity IL-2 receptor (CD25) and effec-
tor function (IFN-γ), we attempted to neutralize IL-2 in vitro in
cocultures of iRBC and splenocytes using supposedly neutraliz-
ing monoclonal antibodies to murine IL-2 (clones S4B6 and JES6;
eBioscience, Hatfield, UK). Unfortunately, these experiments were
unsuccessful, as blocking of IL-2 in vitro gave anomalous and
highly variable results (data not shown), possibly due to the ten-
dency of both antibodies to potentiate IL-2 signaling under certain
conditions [29–31].
However, IFN-γ could be detected in over 30% of murine NK
cells after 19-h culture of na¨ıve C57BL/6 mouse splenocytes with
P. yoelii iRBC (Fig. 5C and D). By contrast, IFN-γ production could
not be detected at all in NK cells from IL-18R−/− mice and was
significantly reduced in NK cells from IL-12 deficient animals. In
confirmation of this, IFN-γ production was completely ablated by
addition of blocking antibodies to IL-12 and IL-18 (Fig. 5C and D).
Discussion
IFN-γ is an important mediator of immune responses to blood-
stage malaria parasites [4, 5, 22, 32]. NK cells are a significant
source of IFN-γ when human PBMC are cocultured in vitro with
P. falciparum iRBC and may be the earliest source of this cytokine
[7, 10]. Although it is difficult to demonstrate directly a role for NK
cells in protective immunity to malaria in humans, human NK cells
have been shown to eliminate P. falciparum iRBCs in a human-
ized mouse model [11] and human population genetic studies are
beginning to reveal associations between NK-cell receptor geno-
type and outcome of malaria infection [33].
In experimental murine malaria infections, NK cells have been
shown to contribute to protection against P. yoelii liver stages
[18], blood-stage P. chabaudi infection [13, 14], and nonlethal
P. yoelii blood stages [5]. IFN-γ is detectable in splenic
homogenates as early as 24 h after infectionwith nonlethal P. yoelii
strains (but not after infection with lethal strains) [34]; IFN-γ is
also detectable (although at reduced concentrations) in athymic
mice lacking T cells [34] but is reduced in animals depleted of NK
cells by administration of anti-asialo GM1 antibody [5, 34]. Taken
together, these data suggest a role for NK cells in the protective
very early IFN-γ response during murine malaria although—as
anti-asialo GM1 antibody also depletes some T-cell populations
[35] and IFN-γ production was not investigated at the cellu-
lar level in these studies—the extent, timing, and significance of
the NK-cell contribution is unclear, as is the pathway of NK-cell
activation.
C© 2015 The Authors. European Journal of Immunology published by
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Figure 4. CD25 expression on NK cells is induced in vitro by IL-12 and IL-18. Splenocytes from naı¨ve, uninfected mice were incubated with varying
concentrations of recombinant IL-12 and IL-18 for 2–6 h and analyzed for CD25 and IFN-γ expression by flow cytometry. (A) Representative dot
plots of CD25 and IFN-γ expression on NK cells after 6-h stimulation with indicated concentrations of IL-12 and IL-18. The gating strategy was
as shown in Figure 1C with additional gating on CD122 to ensure expression of the high-affinity IL-2R. Numbers in each quadrant denote the
percentage of NK cells expressing CD25 and/or IFN-γ. (B) Median MFI CD25 of NK cells after stimulation for 6 h with varying concentrations of IL-12
and IL-18. Data are from one of three independent experiments; the number of samples tested at each concentration is indicated in parentheses
in the key. (C) CD25 expression levels (median MFI) on NK cells after 2- and 4-h stimulation with varying concentrations of IL-12 and IL-18. Data
from one of two independent experiments are shown (n = 5). (D) Proportion of IFN-γ-producing NK cells after stimulation for 6 h with varying
concentrations of IL-12 and IL-18. Data are from one of three independent experiments. The number of samples tested at each concentration is
indicated in the key of (B).
Here, we have shown substantial activation of murine splenic
NK cells within 24 h of blood-stage malaria infection with upreg-
ulation of CD25 (IL-2Rα), the early activation marker CD69, and
IFN-γ. As expression of CD122 (IL-2Rβ) is maintained on NK
cells throughout the infection, this implies that a functional high-
affinity IL-2 receptor is expressed on the activated, CD25+ cells.
NK cells from mice with nonlethal P. yoelii infections responded
more quickly and to a greater extent than did cells from mice
with lethal infections, in agreement with previous findings that
early NK-cell responses correlate with favorable outcomes of
murine malaria infections [5, 34]. These data suggest, but do not
prove, that early and robust NK-cell responses contribute to initial
control of blood-stage malaria infections; NK-cell depletion stud-
ies or NK cell specific gene deletion studies are needed to test this
hypothesis.
In nonlethal Py17XNL infections, CD25 expression was very
highly correlated with IFN-γ production suggesting that these two
responses might be causally associated. Indeed, 24 h after initia-
tion of nonlethal malaria infection, splenic NK cells were hyper-
responsive to IL-2, with exogenous IL-2 inducing an approximate
twofold increase in the proportion of NK cells producing IFN-γ.
Although much lower levels of CD25 were detected on splenic
NK cells 24 h after infection with the lethal strain of P. yoelii,
these also showed increased sensitivity to exogenous IL-2 with
C© 2015 The Authors. European Journal of Immunology published by
WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
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Figure 5. CD25 expression is induced by P. yoelii iRBC and is absolutely dependent upon IL-18. (A–D) Splenocytes from WT C57BL/6 (B6; black
bars), IL-12p35−/– (gray bars), and IL-18R−/− (white bars) mice were cultured for 19 h (with Brefeldin A present for the last 3 h) with uRBCs and iRBCs
in the presence or absence of blocking antibodies to IL-12 and IL-18 or isotype control IgG antibody, and analyzed for (A, B) CD25 and (C, D) IFN-γ
expression. The entire dataset from one of two experiments is shown in (A) and (C) and statistical analyses for iRBC-stimulated cells are shown in
(B) and (D) (n = 3). ANOVA with Tukey’s multiple comparison test was applied. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
substantially augmented IFN-γ responses. These data suggest
that the somewhat attenuated, and more variable, NK-cell IFN-
γ responses observed in mice with lethal compared to nonlethal
infections might result from limitations in the in vivo availability
of IL-2 as well as reliance on signaling via the low-affinity (CD122)
IL-2R rather than the high-affinity (CD25) receptor.
Although murine NK cells are known to respond to IL-2 by pro-
liferation and enhanced cytotoxic function [36], it has long been
assumed that this response is mediated by the low-affinity IL-2R
as studies in the early 1990s failed to detect expression of IL-2Rα
(CD25) in murine NK cells after in vivo administration of IL-2 or
IFN-β or after infection with lymphocytic choriomeningitis virus
[36]. This view has, recently, been revised after the demonstra-
tion of transient expression of CD25 on NK cells from mice 2–3
days after infection with murine cytomegalovirus (MCMV); this
was associated with approximately 100-fold higher NK-cell sen-
sitivity to IL-2 (measured by proliferation) [23]. Optimal CD25
expression during MCMV infection required IL-12/IL-23p40 and
signaling through the IL-12R and STAT4; this may explain the
lack of CD25 induction during lymphocytic choriomeningitis virus
infection in which there is little if any IL-12 response [37]. Fur-
thermore, CD25 could be induced on resting NK cells by a syn-
ergistic combination of 1 ng/mL each of IL-12 and IL-18 [23].
In confirmation of these observations, we have shown here that
1 ng/mL of IL-12 in combination with 1 ng/mL IL-18 induces
maximal expression of CD25 on resting NK cells. However, our
experiments build upon these published data to show that induc-
tion of CD25 is accompanied by IFN-γ production, with more than
90% of the NK cells producing IFN-γ under optimal conditions.
These data are reminiscent of studies with human NK cells in
which high concentrations of IL-12 and IL-18 can, in combina-
tion, induce high levels of IFN-γ, over-riding the need for other
cytokines or contact-mediated signals [27, 38]. For human NK
cells, IL-2 synergizes with IL-12 and IL-18, markedly reducing the
concentrations of IL-12 and IL-18 required to induce robust NK-cell
IFN-γ responses (Wolf et al., unpubl. data). We have evidence for
similar synergy amongmurine NK cells in that exogenous IL-2 sub-
stantially enhanced IFN-γ-production by NK cells from Py17XNL-
and PyYM-infected mice and NK cells within splenocytes from
Rag2 KO mice (which lack T cell derived IL-2) responded very
C© 2015 The Authors. European Journal of Immunology published by
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poorly to Py17XNL- iRBCs (K. Stegmann, unpubl. data). Taken
together, our data indicate that, during an infection, the timing
of the NK-cell response (and hence its contribution to control-
ling the infection) will be highly dependent upon the precise mix
of cytokines being produced, their kinetics, and their respective
concentrations. Further studies are now required to determine
the optimal timing of these responses and their importance for
controlling the initial stages of malaria parasite replication in the
blood.
The robust NK-cell response that we observed during P. yoelii
infection also appears to be IL-12 and IL-18 dependent in that both
CD25 and IFN-γwere strongly upregulated when splenocytes from
WT mice were cocultured with P. yoelii iRBC but this was blocked
by neutralizing antibodies to IL-12 and IL-18. Interestingly, how-
ever, NK-cell activation among splenocytes from IL-12p35 defi-
cient mice was only modestly reduced whereas NK cells from IL-
18R deficient mice were completely nonresponsive to iRBC. Pre-
liminary experiments indicate that the NK cells themselves (rather
than another cell type in the spleen) must express IL-18R since NK
cells from (CD45.2+) IL-18R−/− mice responded poorly to iRBC
when cocultured with splenocytes from WT (CD45.1+) C57BL/6
mice (K. Stegmann, unpubl. data). Our data also suggest that the
requirement for IL-12 might be over-ridden by provision of other
cytokines (such as IL-2 or IL-15; notably addition of a very low
concentration of IL-15 to the culture medium was essential for
NK survival in these experiments) but that the IL-18-mediated sig-
nals are essential and nonredundant. Previous in vivo studies have
demonstrated an apparently essential role for IL-12 in activation
of NK cells to produce IFN-γ during P. chabaudi [13, 14, 39] and
P. berghei [40] infections but, although IL-18 has been causally
linked to IFN-γ production and protection in P. yoelii and P. berghei
infections [41, 42], this is the first demonstration of an essen-
tial role for IL-18 in NK-cell activation during murine malaria.
Although the precise sources of IL-12 and IL-18 during very early
P. yoelii infection remain to be determined, DCs and Ly6C+ CCR2+
inflammatory monocytes have been implicated as major sources of
IL-12 and IL-18, respectively, during infections with other rodent
malaria species [14, 40, 41].
In conclusion, we have shown that NK cells upregulate CD25
very early during experimental malaria infection, that induction
of CD25 is entirely dependent upon IL-18-mediated signals, that
extremely low concentrations of IL-12 and IL-18 can synergize
to induce CD25, that CD25 expression is tightly correlated with
induction of IFN-γ, and that exogenous IL-2 can enhance IFN-
γ production. These data suggest that, as for human NK cells
responding to P. falciparum-iRBCs [10], IL-2-mediated signal-
ing pathways synergize with cytokine and/or contact-mediated
signals from myeloid cells to maximize the very early IFN-γ
response to blood-stage malaria infection and that this response
may be a crucial determinant of the eventual outcome of infec-
tion. Our data also imply that CD4+ or CD8+ T cells—the major
source of IL-2 in most systems—may also play a role in amplifying
NK-cell responses and thus that IL-2 production by memory T cells
may represent an important effector response during re-infection
or after vaccination.
Materials and methods
Animals and parasites
Female C57BL/6N (WT) mice were bred at the London School of
Hygiene and Tropical Medicine or purchased from Charles River
Laboratories (Margate, UK); IL-12 deficient mice (IL-12p35−/−) or
mice lacking the IL-18 receptor (IL-18R−/−) were bred at the Lon-
don School of Hygiene and Tropical Medicine and were shown
to be free from prevalent bacterial, viral, fungal, and parasitic
pathogens. All animal experiments were performed in accordance
with the Animals (Scientific Procedures) Act of 1986 and were
approved by the animal welfare and ethical review board of the
London School of Hygiene and Tropical Medicine. Animals were
housed in individually ventilated cages (three to five animals per
cage) maintained in a 12 h light/12 h dark light cycle with envi-
ronmental enrichment and received RM1 diet. Individual cages
were randomly assigned to infection or control groups.
Cryopreserved P. yoelii parasites were thawed and passaged in
vivo. Seven- to 10-week-old female mice were infected i.p. with
105 iRBC; control mice were either na¨ıve or treated with PBS or
uRBC. Parasitemia was assessed every second day by the exami-
nation of Giemsa-stained thin blood smears. Mice were killed by
CO2 inhalation on selected days p.i. Single cell splenocyte suspen-
sions were prepared by homogenization and sieving through a 70
μm cell strainer (BD Bioscience (BD), Oxford, UK). Samples were
incubated in RBC lysis buffer (BD), washed, and resuspended in
HBSS + 2% FCS (both Gibco Life Technologies, Paisley, UK).
Flow cytometry
Cell preparations for phenotypic characterization directly ex vivo
were processed and fixed within 2 h of collection, were kept
on ice during processing, and were centrifuged at 4°C. Single
cell suspensions were first stained with anti-mouse CD122 (clone
5H4, eBioscience), anti-mouse CD25 (clone PC64.5, eBioscience),
anti-mouse CD3 (clone 500A2, BD), anti-mouse NKp46 (clone
29A1.4, BD), anti-mouse CD69 (clone H1.2, eBioscience), anti-
mouse TRAIL (clone N2B2, eBioscience), anti-mouse CD107a
(clone 1D4B, eBioscience), and Live/Dead Fixable Near IR Dead
Cell Stain Kit (Invitrogen) for 20 min at 4°C in the dark. After
washing twice with HBSS + 2% FCS, cells were either fixed
using 2% paraformaldehyde in PBS or permeabilized in BD
Cytofix/Cytoperm for staining of intracellular cytokines for 20 min
at 4°C. Before intracellular staining with anti-mouse IFN-γ (clone
XMG1.2, eBioscience), anti-mouse TNF (clone MP6-XT22, eBio-
science), and anti-mouse Granzyme B (clone 16G6, eBioscience)
for 20 min at 4°C in the dark, cells were washed twice with BD
Perm/Wash buffer. After staining, cells werewashed twicewith BD
Perm/Wash buffer and thereafter fixed using 2% paraformalde-
hyde in PBS for 20 min at 4°C. After a final wash, cells were
resuspended in PBS. Samples were acquired using a BD LSRII
flow cytometer and BD FACSDiva 6.0 (BD Bioscience). Data were
analyzed using FlowJo for PC (TreeStar, Ashland, OR, USA).
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In vitro stimulation of splenocytes
In in vitro experiments, cell suspensions were stimulated with
recombinant mouse IL-2 (eBioscience) for 4 h and with IL-12
(R&D, Abingdon, UK) and/or IL-18 (MBL, Woburn, MA) for 2–
6 h at 37°C at 5% CO2 with Brefeldin A (Sigma-Aldrich, Dorset,
UK) present for the last 3 h of incubation when IFN-γ was ana-
lyzed alone or without Brefeldin A when CD25 and IFN-γ were
analyzed simultaneously. Stimulated cells were characterized by
flow cytometry as described above.
Coculture assay of splenocytes and RBC
In coculture experiments, isolated splenocytes of WT, IL-
12p35−/−, and IL-18R−/−mice were cultured in RPMI1640 supple-
mented with 10% FCS, 100 U/mL penicillin/streptomycin, and 2
mM L-glutamine (all Gibco Life Technologies) containing 2 ng/mL
recombinant mouse IL-15 (Peprotech, Rocky Hill, NJ, USA) with
uRBC or Py17XNL iRBC at a ratio of 5 uRBC/iRBC per splenocyte.
iRBCs were purified from blood obtained from Py17XNL-infected
WT animals by passage over a magnetic column (Miltenyi Biotech,
Bergisch-Gladbach, Germany). Blocking antibodies to IL-12p35
(eBioscience) and IL-18 (MBL) or control rat IgG1 or IgG2a (both
eBioscience) were added at a concentration of 2.5 μg/mL. Cells
were cultured at 37°C at 5% CO2 for 19 h with Brefeldin A present
for the last 3 h of culture. Stimulated cells were characterized by
flow cytometry as described above.
Statistical analysis
Data are represented as means ± SEM. In Figure 3, data are pre-
sented as means of each day of infection showing individual data
points and as individual data points for IL-2 stimulation. Prism
6 (GraphPad Software, La Jolla, CA, USA) was used for prepa-
ration of figures and for statistical analysis. Kruskal–Wallis with
Dunn’s post-test was used to compare experimental and control
animals during the course of infection, Wilcoxon test was used to
compare paired samples stimulated with IL-2, and ANOVA with
Tukey’s multiple comparison test was used to compare coculture
experiments using different transgenic mouse strains.
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